173 related articles for article (PubMed ID: 30816476)
1. MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway.
Liu Y; Wang Y; Yang H; Zhao L; Song R; Tan H; Wang L
Int J Oncol; 2019 May; 54(5):1809-1820. PubMed ID: 30816476
[TBL] [Abstract][Full Text] [Related]
2. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
Liu L; Wang R; Zhang Z; Wang X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA KCNQ1OT1 contributes to tumor growth and activates Wnt/β‑catenin signaling in osteosarcoma by targeting the miR‑3666/KLF7 axis.
Huang A; Jin S; Han W; Wang Y; Ma S; Wang Z; Lin K; Zou Q; Zhou J; Li Z; Chen L
Int J Mol Med; 2021 Jan; 47(1):387-396. PubMed ID: 33416089
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
5. lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
Wang H; Zhang P
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760218
[TBL] [Abstract][Full Text] [Related]
6. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
Wu Z; Shi W; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑873 inhibits the progression of thyroid cancer by directly targeting ZEB1.
Jiao D; Guo F; Fu Q
Mol Med Rep; 2019 Aug; 20(2):1986-1993. PubMed ID: 31257462
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-221 Promotes Cell Proliferation and Inhibits Apoptosis in Osteosarcoma Cells by Directly Targeting FBXW11 and Regulating Wnt Signaling.
Zhang Q; Yin X; Zhang Y
Arch Med Res; 2021 Feb; 52(2):191-199. PubMed ID: 33131925
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway.
Zhao X; Li J; Yu D
Int J Mol Med; 2019 Nov; 44(5):1833-1843. PubMed ID: 31545400
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-1294 targets HOXA9 and has a tumor suppressive role in osteosarcoma.
Zhang ZF; Li GR; Cao CN; Xu Q; Wang GD; Jiang XF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8582-8588. PubMed ID: 30575897
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis.
Xia P; Gu R; Zhang W; Shao L; Li F; Wu C; Sun Y
J Cell Physiol; 2019 Dec; 234(12):22787-22798. PubMed ID: 31152456
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
Tan X; Jiang L; Wu X; Feng W; Lin Q
Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
Zhang C; Hu Y; Wan J; He H
Oncol Rep; 2015 Oct; 34(4):2195-201. PubMed ID: 26259653
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
15. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
Yang G; Zhang C; Wang N; Chen J
Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma.
Han C; Wang W
Mol Med Rep; 2018 Mar; 17(3):4777-4784. PubMed ID: 29328417
[TBL] [Abstract][Full Text] [Related]
18. miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells.
Li Z; Li Y; Wang N; Yang L; Zhao W; Zeng X
Biochem Biophys Res Commun; 2016 Mar; 471(4):479-85. PubMed ID: 26902120
[TBL] [Abstract][Full Text] [Related]
19. Long non‑coding RNA GHET1 promotes osteosarcoma development and progression via Wnt/β‑catenin signaling pathway.
Chen X; Zhao W; Fan W
Oncol Rep; 2020 Jul; 44(1):349-359. PubMed ID: 32319657
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑944 targets vascular endothelial growth factor to inhibit cell proliferation and invasion in osteosarcoma.
Yan T; Zhu S; Zhang J; Lu G; Lv C; Wei Y; Luo M
Mol Med Rep; 2018 Dec; 18(6):5221-5228. PubMed ID: 30280196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
